Nodules, CT-scans and PET-scans: a good partnershipVANSTEENKISTE, Johan F.Lung cancer. 2004, Vol 45, Num 1, pp 29-30, issn 0169-5002, 2 p.Article

Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer : How CONSORTed are the data?PAT, Karin; DOOMS, Christophe; VANSTEENKISTE, Johan et al.Lung cancer. 2008, Vol 62, Num 1, pp 126-138, issn 0169-5002, 13 p.Article

Value of FDG-PET in the management of non-small cell lung cancerSTROOBANTS, Sigrid; VERSCHAKELEN, Johny; VANSTEENKISTE, Johan et al.European journal of radiology. 2003, Vol 45, Num 1, pp 49-59, issn 0720-048X, 11 p.Article

Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experienceMELLSTEDT, Håkan; VANSTEENKISTE, Johan; THATCHER, Nick et al.Lung cancer. 2011, Vol 73, Num 1, pp 11-17, issn 0169-5002, 7 p.Article

Improving patient management in metastatic non-small cell lung cancerVANSTEENKISTE, Johan.Lung cancer. 2007, Vol 57, issn 0169-5002, S12-S17, SUP2Article

The future of adjuvant chemotherapy for resected non-small cell lung cancerVANSTEENKISTE, Johan F; SCHILDERMANS, Rob H.Expert review of anticancer therapy. 2005, Vol 5, Num 1, pp 165-175, issn 1473-7140, 11 p.Article

Positron emission tomography in the management of non-small cell lung cancerVANSTEENKISTE, Johan F; STROOBANTS, Sigrid G.Hematology/oncology clinics of North America. 2004, Vol 18, Num 1, issn 0889-8588, xiii, 269-288 [21 p.]Article

Second-line therapeutic options in non-small-cell lung cancerVANSTEENKISTE, Johan.Lung cancer. 2006, Vol 54, issn 0169-5002, S15-S18, SUP2Article

Interstitial lung diseases: characteristics at diagnosis and mortality risk assessmentTHOMEER, Michiel J; VANSTEENKISTE, Johan; VERBEKEN, Eric K et al.Respiratory medicine. 2004, Vol 98, Num 6, pp 567-573, issn 0954-6111, 7 p.Article

PET scan in the staging of non-small cell lung cancerVANSTEENKISTE, Johan F.Lung cancer. 2003, Vol 42, pp S27-S37, issn 0169-5002, SUP1Conference Paper

Chemotherapy-induced anemia: the story of darbepoetin alfaVANSTEENKISTE, Johan; WAUTERS, Isabelle; ELLIOTT, Steven et al.Current medical research and opinion. 2013, Vol 29, Num 4, pp 325-337, issn 0300-7995, 13 p.Article

The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancerDOOMS, Christophe A; PAT, Karin E; VANSTEENKISTE, Johan F et al.Expert review of anticancer therapy. 2006, Vol 6, Num 4, pp 531-544, issn 1473-7140, 14 p.Article

Mediastinal emphysema and small cell lung cancer (SCLC): a case-reportLIBEER, Christophe; VERBEKEN, Eric; DE WEVER, Walter et al.Lung cancer. 2005, Vol 47, Num 1, pp 139-142, issn 0169-5002, 4 p.Article

Darbepoetin alfa for the treatment of chemotherapy-induced anemia : Disease progression and survival analysis from four randomized, double-blind, placebo-controlled trialsHEDENUS, Michael; VANSTEENKISTE, Johan; KOTASEK, Dusan et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 6941-6948, issn 0732-183X, 8 p.Article

Fatal pulmonary veno-occlusive disease possibly related to gemcitabineVANSTEENKISTE, Johan F; BOMANS, Peter; VERBEKEN, Eric K et al.Lung cancer. 2001, Vol 31, Num 1, pp 83-85, issn 0169-5002Article

Staging proceduresVANSTEENKISTE, Johan; DOOMS, Christophe; BECKER, Heinrich et al.European journal of cancer. Supplement (1990). 2005, Vol 3, Num 3, pp 7-19, issn 1359-6349, 13 p.Conference Paper

Impact of FDG-PET-Induced Treatment Choices on Long-Term Outcome in Non-Small Cell Lung CancerWAUTERS, Isabelle; STROOBANTS, Sigrid; DE LEYN, Paul et al.Respiration (Basel). 2010, Vol 79, Num 2, pp 97-104, issn 0025-7931, 8 p.Article

Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experienceSCHREVENS, Liesbet; VANSTEENKISTE, Johan; DENEFFE, Georges et al.Lung cancer. 2004, Vol 43, Num 1, pp 39-45, issn 0169-5002, 7 p.Article

Prognostic Stratification of Stage IIIA-N2 Non-Small-Cell Lung Cancer After Induction Chemotherapy : A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission TomographyDOOMS, Christophe; VERBEKEN, Eric; STROOBANTS, Sigrid et al.Journal of clinical oncology. 2008, Vol 26, Num 7, pp 1128-1134, issn 0732-183X, 7 p.Article

Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survivalDECALUWE, Herbert; DE LEYN, Paul; VANSTEENKISTE, Johan et al.European journal of cardio-thoracic surgery. 2009, Vol 36, Num 3, pp 433-439, issn 1010-7940, 7 p.Conference Paper

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung CancerVITTORIO SCAGLIOTTI, Giorgio; PARIKH, Purvish; LEE, Jin S et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3543-3551, issn 0732-183X, 9 p.Article

The maximum uptake of ¹⁸F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-lα and GLUT-1 in non-small cell lung cancerVAN BAARDWIJK, Angela; DOOMS, Christophe; LAMBIN, Philippe et al.European journal of cancer (1990). 2007, Vol 43, Num 9, pp 1392-1398, issn 0959-8049, 7 p.Article

Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer : A leuven lung cancer group studyGOLDSTRAW, Peter; DE LEYN, Paul; NACKAERTS, Kristiaan et al.Journal of clinical oncology. 2006, Vol 24, Num 21, issn 0732-183X, 3317-3318,3333-3339 [9 p.]Article

Ceritinib in ALK-Rearranged Non―Small-Cell Lung CancerSHAW, Alice T; KIM, Dong-Wan; RIELY, Gregory J et al.The New England journal of medicine. 2014, Vol 370, Num 13, pp 1189-1197, issn 0028-4793, 9 p.Article

Adjuvant MAGE-A3 Immunotherapy in Resected Non-Small-Cell Lung Cancer: Phase II Randomized Study ResultsVANSTEENKISTE, Johan; ZIELINSKI, Marcin; PERDEUS, Jakub et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2396-2403, issn 0732-183X, 8 p.Article